Atrial natriuretic peptide and regulation of vascular function in hypertension and heart failure: Implications for novel therapeutic strategies

Speranza Rubattu, Camilla Calvieri, Beniamino Pagliaro, Massimo Volpe

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Atrial natriuretic peptide (ANP) plays a pivotal role in modulation of vascular function and it is also involved in the pathophysiology of several cardiovascular diseases. We provide an updated overview of the current appraisal of ANP vascular effects in both animal models and humans. We describe the physiological implications of ANP vasomodulatory properties as well as the involvement of ANP, through its control of vascular function, in hypertension and heart failure. The principal molecular mechanisms underlying regulation of vascular tone, that is natriuretic peptide receptor type A/cyclic guanylate monophosphate, natriuretic peptide receptor type C, nitric oxide system, are discussed. We review the literature on therapeutic implications of ANP in hypertension and heart failure, examining the potential use of ANP analogues, neutral endopeptidase (NEP) inhibitors, ACE/NEP inhibitors, angiotensin receptor blocker (ARB)/NEP inhibitors, the new dual endothelin-converting enzyme (ECE)/NEP inhibitors and ANP-based gene therapy. The data discussed support the role of ANP in different pathological conditions through its vasomodulatory properties. They also indicate that ANP may represent an optimal therapeutic agent in cardiovascular diseases.

Original languageEnglish
Pages (from-to)1061-1072
Number of pages12
JournalJournal of Hypertension
Volume31
Issue number6
DOIs
Publication statusPublished - Jun 2013

Fingerprint

Atrial Natriuretic Factor
Blood Vessels
Heart Failure
Hypertension
Neprilysin
Protease Inhibitors
Therapeutics
Cardiovascular Diseases
Angiotensin Receptor Antagonists
Genetic Therapy
Nitric Oxide
Animal Models

Keywords

  • ANP analogues
  • atrial natriuretic peptide
  • gene therapy
  • nitric oxide
  • NPR-A
  • NPR-C
  • vascular function
  • vasopeptidase inhibitors

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Atrial natriuretic peptide and regulation of vascular function in hypertension and heart failure : Implications for novel therapeutic strategies. / Rubattu, Speranza; Calvieri, Camilla; Pagliaro, Beniamino; Volpe, Massimo.

In: Journal of Hypertension, Vol. 31, No. 6, 06.2013, p. 1061-1072.

Research output: Contribution to journalArticle

@article{e532a23512684737abed6c3ebb14a395,
title = "Atrial natriuretic peptide and regulation of vascular function in hypertension and heart failure: Implications for novel therapeutic strategies",
abstract = "Atrial natriuretic peptide (ANP) plays a pivotal role in modulation of vascular function and it is also involved in the pathophysiology of several cardiovascular diseases. We provide an updated overview of the current appraisal of ANP vascular effects in both animal models and humans. We describe the physiological implications of ANP vasomodulatory properties as well as the involvement of ANP, through its control of vascular function, in hypertension and heart failure. The principal molecular mechanisms underlying regulation of vascular tone, that is natriuretic peptide receptor type A/cyclic guanylate monophosphate, natriuretic peptide receptor type C, nitric oxide system, are discussed. We review the literature on therapeutic implications of ANP in hypertension and heart failure, examining the potential use of ANP analogues, neutral endopeptidase (NEP) inhibitors, ACE/NEP inhibitors, angiotensin receptor blocker (ARB)/NEP inhibitors, the new dual endothelin-converting enzyme (ECE)/NEP inhibitors and ANP-based gene therapy. The data discussed support the role of ANP in different pathological conditions through its vasomodulatory properties. They also indicate that ANP may represent an optimal therapeutic agent in cardiovascular diseases.",
keywords = "ANP analogues, atrial natriuretic peptide, gene therapy, nitric oxide, NPR-A, NPR-C, vascular function, vasopeptidase inhibitors",
author = "Speranza Rubattu and Camilla Calvieri and Beniamino Pagliaro and Massimo Volpe",
year = "2013",
month = "6",
doi = "10.1097/HJH.0b013e32835ed5eb",
language = "English",
volume = "31",
pages = "1061--1072",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Atrial natriuretic peptide and regulation of vascular function in hypertension and heart failure

T2 - Implications for novel therapeutic strategies

AU - Rubattu, Speranza

AU - Calvieri, Camilla

AU - Pagliaro, Beniamino

AU - Volpe, Massimo

PY - 2013/6

Y1 - 2013/6

N2 - Atrial natriuretic peptide (ANP) plays a pivotal role in modulation of vascular function and it is also involved in the pathophysiology of several cardiovascular diseases. We provide an updated overview of the current appraisal of ANP vascular effects in both animal models and humans. We describe the physiological implications of ANP vasomodulatory properties as well as the involvement of ANP, through its control of vascular function, in hypertension and heart failure. The principal molecular mechanisms underlying regulation of vascular tone, that is natriuretic peptide receptor type A/cyclic guanylate monophosphate, natriuretic peptide receptor type C, nitric oxide system, are discussed. We review the literature on therapeutic implications of ANP in hypertension and heart failure, examining the potential use of ANP analogues, neutral endopeptidase (NEP) inhibitors, ACE/NEP inhibitors, angiotensin receptor blocker (ARB)/NEP inhibitors, the new dual endothelin-converting enzyme (ECE)/NEP inhibitors and ANP-based gene therapy. The data discussed support the role of ANP in different pathological conditions through its vasomodulatory properties. They also indicate that ANP may represent an optimal therapeutic agent in cardiovascular diseases.

AB - Atrial natriuretic peptide (ANP) plays a pivotal role in modulation of vascular function and it is also involved in the pathophysiology of several cardiovascular diseases. We provide an updated overview of the current appraisal of ANP vascular effects in both animal models and humans. We describe the physiological implications of ANP vasomodulatory properties as well as the involvement of ANP, through its control of vascular function, in hypertension and heart failure. The principal molecular mechanisms underlying regulation of vascular tone, that is natriuretic peptide receptor type A/cyclic guanylate monophosphate, natriuretic peptide receptor type C, nitric oxide system, are discussed. We review the literature on therapeutic implications of ANP in hypertension and heart failure, examining the potential use of ANP analogues, neutral endopeptidase (NEP) inhibitors, ACE/NEP inhibitors, angiotensin receptor blocker (ARB)/NEP inhibitors, the new dual endothelin-converting enzyme (ECE)/NEP inhibitors and ANP-based gene therapy. The data discussed support the role of ANP in different pathological conditions through its vasomodulatory properties. They also indicate that ANP may represent an optimal therapeutic agent in cardiovascular diseases.

KW - ANP analogues

KW - atrial natriuretic peptide

KW - gene therapy

KW - nitric oxide

KW - NPR-A

KW - NPR-C

KW - vascular function

KW - vasopeptidase inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84877585683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877585683&partnerID=8YFLogxK

U2 - 10.1097/HJH.0b013e32835ed5eb

DO - 10.1097/HJH.0b013e32835ed5eb

M3 - Article

C2 - 23524910

AN - SCOPUS:84877585683

VL - 31

SP - 1061

EP - 1072

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 6

ER -